SCHEMBL6166050

SCHEMBL6166050

O=C1CCc2c1c(-c1ccncc1)nn2CCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.47
PKN1 Q16512 3/20 0.43
PKN2 Q16513 3/20 0.43
CDC7 O00311 2/20 0.43
RIPK3 Q9Y572 2/20 0.39
BUB1 O43683 6/20 0.38
BRAF P15056 5/20 0.38
MAPK10 P53779 3/20 0.38
BMPR1B O00238 2/20 0.38
CIT O14578 2/20 0.38
RIPK2 O43353 2/20 0.38
STK10 O94804 2/20 0.38
MAP4K4 O95819 2/20 0.38
ABL1 P00519 2/20 0.38
RAF1 P04049 2/20 0.38
ERBB3 P21860 2/20 0.38
JAK1 P23458 2/20 0.38
ACVR1B P36896 2/20 0.38
TGFBR1 P36897 2/20 0.38
CSNK1D P48730 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164169 0.88 HTT (0.48) HTTALDH1A1
SCHEMBL6167036 0.83 RIPK3 (0.39) PKN1PKN2CDC7RIPK3BUB1
SCHEMBL6164255 0.82 HTT (0.46) HTTALDH1A1
SCHEMBL6167339 0.79 HTT (0.45) HTTRAF1ALDH1A1
SCHEMBL6164980 0.78 HTT (0.44) HTT
SCHEMBL6164796 0.76 HTT (0.43) HTTRIPK2MAPK1ALDH1A1
SCHEMBL6161914 0.75 HTT (0.44) HTTMAPK1ALDH1A1
SCHEMBL6166822 0.75 HTT (0.44) HTTALDH1A1
SCHEMBL6162358 0.74 HTT (0.46) HTTABL1ALDH1A1
SCHEMBL6164630 0.72 HTT (0.41) HTTMAPK10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed